Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients.

Autor: Ferraz-Amaro I; Servicio de Reumatologia, Hospital Universitario de Canarias, La Laguna, Spain., Genre F; Grupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain., Blanco R; Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.; Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Calvo-Rio V; Grupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Reumatologia, Hospital Universitario Marques de Valdecilla, Santander, Spain., Corrales-Selaya C; Grupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Hospital Universitario Marqués de Valdecilla, Servicio de Reumatología, Santander, Spain., Portilla V; Hospital Universitario Marques de Valdecilla, Santander, Spain., Aurrecoechea E; Rheumatology, Hospital Sierrallana, Torrelavega, Spain., Batanero R; Endocrino, Hospital Universitario Marques de Valdecilla, Santander, Spain., Hernández-Hernández V; Hospital Universitario de Canarias, La Laguna, Spain., Quevedo-Abeledo JC; Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Rodríguez-Lozano C; Rheumatology Department, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain., López-Medina C; Rheumatology, Reina Sofia University Hospital, Cordoba, Spain.; GC05, Maimonides Biomedical Research Institute of Cordoba, Cordoba, Spain., Ladehesa-Pineda L; University of Cordoba, Cordoba, Spain., Castañeda S; Rheumatology Department, Hospital Universitario La Princesa, Madrid, Spain.; Rheumatology, FJD, Madrid, Spain., Vicente-Rabaneda EF; Rheumatology, Hospital de La Princesa, Madrid, Spain., Fernández-Carballido C; Rheumatology, Hospital General Universitario de Elda, Elda, Spain., Martínez Vidal MP; Hospital General Universitario de Alicante, Alicante, Spain., Castro Corredor D; Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Anino Fernández J; Rheumatology Department, Ciudad Real General Hospital, Ciudad Real, Spain., Peiteado D; Hospital Universitario La Paz, Madrid, Spain., Plasencia-Rodriguez C; Rheumatology, Hospital Universitario La Paz, Madrid, Spain., Expósito R; Hospital Universitario Basurto, Bilbao, Spain., Garcia Vivar ML; Department of Rheumatology, Osakidetza Basque Health Service, Basurto University Hospital, Barcelona, Spain., Galíndez-Agirregoikoa E; Reumatologia, Hospital de Basurto, Basurto, Spain., Vegas N; Reumatologia, Hospital de Galdakao-Usansolo, Galdakao, Spain., Urionagüena I; Rheumatology Division, Hospital Universitario Cruces, Barakaldo, Spain., Montes-Perez E; Diagnóstico Médico Cantabria (DMC), Santander, Spain., Gonzalez-Gay MA; Rheumatology, ISS Fundacion Jimenez Diaz, Madrid, Spain miguelaggay@hotmail.com.; Department of Medicine and Psychiatry, Medicine, University of Cantabria, Santander, Spain., Rueda-Gotor J; Grupo Inmunopatología, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.; Reumatologia, Hospital Sierrallana y Tres Mares, Torrelavega, Spain.

Publikováno v: RMD open [RMD Open] 2024 Jun 28; Vol. 10 (2). Date of Electronic Publication: 2024 Jun 28.

Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.

Autor: Loganathan A; Royal National Hospital for Rheumatic Diseases, Bath; Department of Life Sciences, University of Bath, UK; and Arthritis Australia, Broadway, Glebe, NSW, Australia., Zanframundo G; Department of Internal Medicine and Therapeutics, Università di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Yoshida A; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan., Faghihi-Kashani S; Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, CA, USA., Bauer Ventura I; Department of Medicine, Section of Rheumatology, University of Chicago, IL, USA., Dourado E; Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro; Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance, Aveiro; and Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Portugal., Bozan F; Hospital Clínico Universidad de Chile, Department of Medicine, Section of Rheumatology, Chile., Sambataro G; Regional Referral Center for Rare Lung Disease, Policlinico G. Rodolico-San Marco, University of Catania, Italy., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Japan., Bae SS; Department of Medicine, Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles, CA, USA., Lim D; Department of Dermatology, Perelman School of Medicine & Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA, USA., Ceribelli A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele; and Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy., Isailovic N; Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy., Selmi C; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele; and Rheumatology and Clinical Immunology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy., Fertig N; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Bravi E; Ospedale Guglielmo da Saliceto, Piacenza, Italy., Kaneko Y; Keio University School of Medicine, Tokyo, Japan., Saraiva AP; Centro Hospitalar e Universitário de Coimbra, Portugal., Jovani V; Department of Rheumatology, Hospital General Universitario Dr. Balmis Alicante, ISABIAL, Alicante, Spain., Bachiller-Corral J; Hospital Universitario Ramon y Cajal, Madrid, Spain., Cifrian J; Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Santander, Spain., Mera-Varela A; Hospital Clínico Universitario de Santiago de Compostela, Spain., Moghadam-Kia S; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Wolff V; Instituto Nacional del Torax, Santiago, Chile., Campagne J; HP Metz, Hopital Belle-Ile, Metz, France., Meyer A; Exploration Fonctionnelle Musculaire, Service de Physiologie, Service de Rhumatologie, Centre de Référence des Maladies Auto-Immunes Systémiques Rares RESO Hôpitaux Universitaires de Strasbourg, France., Giannini M; Exploration Fonctionnelle Musculaire, Service de Physiologie, Service de Rhumatologie, Centre de Référence des Maladies Auto-Immunes Systémiques Rares RESO Hôpitaux Universitaires de Strasbourg, France., Triantafyllias K; ACURA Center for Rheumatic Diseases, Bad Kreuznach, Germany., Knitza J; University of Erlangen, Germany., Gupta L; Department of Clinical Immunology and Rheumatology, SGPGIMS, Lucknow, India., Molad Y; Rabin Medical Center, Beilinson Hospital, and Sackler Faculty of Medicine, Tel Aviv University, Israel., Iannone F; University of Bari, Italy., Cavazzana I; University and AO Spedali Civili, Brescia, Italy., Piga M; University Clinic and AOU of Cagliari, Italy., De Luca G; IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Tansley S; Royal National Hospital for Rheumatic Diseases, Bath, and Department of Life Sciences, University of Bath, UK., Bozzalla-Cassione E; Department of Internal Medicine and Therapeutics, Università di Pavia, and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Bonella F; Center for Interstitial and Rare Lung Diseases, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany., Corte TJ; University of Sydney, NSW, and Royal Prince Alfred Hospital, NSW, Australia., Doyle TJ; Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Fiorentino D; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA., Gonzalez-Gay MA; Medicine and Psychiatry Department, University of Cantabria, and Division of Rheumatology, IIS-Fundacion Jiménez Díaz, Madrid, Spain., Hudson M; Department of Medicine, McGill University, Montreal, Quebec, Canada., Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan., Lundberg IE; Karolinska Institute, Stockholm, Sweden., Mammen AL; National Institute of Arthritis and Musculoskeletal and Skin Disorders, National Institutes of Health, Bethesda, MD, and Departments of Medicine and Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., McHugh NJ; Department of Life Sciences, University of Bath, UK., Miller FW; Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA., Montecucco C; Department of Internal Medicine and Therapeutics, Università di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Oddis CV; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Rojas-Serrano J; Interstitial Lung Disease and Rheumatology Units, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, México City, México., Schmidt J; University of Gottingen, Germany., Scirè CA; IRCCS San Gerardo dei Tintori Foundation, Monza, and School of Medicine, University of Milano Bicocca, Milan, Italy., Selva-O'Callaghan A; Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d'Hebron General Hospital, Universitat Autonoma de Barcelona, Spain., Werth VP; Department of Dermatology, Perelman School of Medicine & Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, Philadelphia, PA, USA., Alpini C; Laboratory of Biochemical-Chemistry, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy., Bozzini S; US Transplant Center, Laboratorio di Biologia Cellulare e Immunologia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy., Cavagna L; Department of Internal Medicine and Therapeutics, Università di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. lorenzo.cavagna@unipv.it., Aggarwal R; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Feb; Vol. 42 (2), pp. 277-287. Date of Electronic Publication: 2024 Mar 14.

Biologic therapy in refractory neurobehcet's disease: a multicentre study of 41 patients and literature review

Autor: Herrero-Morant, A, Martin-Varillas, JL, Castaneda, S, Maiz, O, Sanchez, J, Ortego, N, Raya, E, Prior-Espanol, A, Moriano, C, Melero-Gonzalez, RB, Grana-Gil, J, Urruticoechea-Arana, A, Ramos-Calvo, A, Loredo-Martinez, M, Salgado-Perez, E, Sivera, F, Torre, I, Narvaez, J, Andreu, JL, Martinez-Gonzalez, O, Gomez-de la Torre, R, Fernandez-Aguado, S, Romero-Yuste, S, Gonzalez-Mazon, I, Alvarez-Reguera, C, Hernandez, JL, Gonzalez-Gay, MA, Blanco, R

Publikováno v: Rheumatology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Objectives To assess efficacy and safety of biologic therapy (BT) in neurobehcet's disease (NBD) refractory to glucocorticoids and at least one conventional immunosuppressive drug. Methods Open-label, national, multicentre study. NBD diagnosis was ba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c108bcf8965a277911e24a671020f080
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7312

Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosus.

Autor: Ferraz-Amaro I; Division of Rheumatology, Hospital Universitario de Canarias, Tenerife, Spain. iferrazamaro@hotmail.com., Gonzalez-Gay MA; Division of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid, and Department of Medicine, University of Cantabria, IDIVAL, Santander, Spain.

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2023 Jul; Vol. 41 (7), pp. 1566. Date of Electronic Publication: 2023 Mar 02.

Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease

Autor: Remuzgo-Martínez, Sara, Genre, Fernanda, Pulito-Cueto, Verónica, Atienza-Mateo, Belén, Mora Cuesta, Víctor Manuel, Iturbe Fernández, David, Fernández Rozas, Sonia María, Lera-Gómez, Leticia, Alonso Lecue, Pilar, Ussetti, María Piedad, Laporta, Rosalía, Berastegui García, Cristina, Solé, Amparo, Pérez González, Virginia Luz, De Pablo Gafas, Alicia, Gualillo, Oreste, Cifrián, José Manuel, López-Mejías, Raquel, Gonzalez-Gay, MA, Universitat Autònoma de Barcelona

Publikováno v: Biomedicines, Vol 9, Iss 458, p 458 (2021)
Biomedicines
Volume 9
Issue 5
Scientia
Biomedicines . 2021 Apr 22;9(5):458
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Biomarker; Interstitial lung disease; Vascular endothelial growth factor Biomarcador; Malaltia pulmonar intersticial; Factor de creixement endotelial vascular Biomarcador; Enfermedad pulmonar intersticial; Factor de crecimiento vascular endotelial Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b03977d86c2562597f540c38ff3003
https://www.mdpi.com/2227-9059/9/5/458